IGAP
GlucoTrack, Inc. [IGAP] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IGAP Stock Summary
In the News
IGAP Financial details
Company Rating
-
Market Cap
50.23M
Income
-2.65M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
11
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.89
Forward P/E
-
PEG
0.2
P/S
-
P/B
0.7
P/C
-
P/FCF
-1.33
Quick Ratio
6.87
Current Ratio
6.91
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.16
EPS next Y
-
EPS next Q
-
EPS this Y
17.24%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
2.53%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-223.97%
-
-
-
-
SMA20
-3.91%
SMA50
-25%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-65%
ROE
-58%
ROC
-0.76%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.24-3.3099
52W High
-60.17%
52W Low
-60.17%
RSI
39.99
Rel Volume
0.01
Avg Volume
5.95K
Volume
32
Perf Week
-6.64%
Perf Month
-20.73%
Perf Quarter
-
Perf Half Y
-35.41%
-
-
-
-
Beta
-1.66486
-
-
Volatility
0.02%, 0.08%
Prev Close
0%
Price
1.195
Change
0%
Company Profile
- Volume Average 5.95K
- Market Capitalization 50.23M
- Employee 11
- CEO Mr. David Malka
- Headquarters Ashdod,IL
- IPO Date 2013-04-25
-
Website
https://www.glucotrack.com 
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Europe and the Asia Pacific. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
